Miao Cui, M.D. Titles and Appointments Assistant Professor Schools Medical School Departments Pathology You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Miao Cui, M.D., M.S., is an Assistant Professor of Pathology at UT Southwestern Medical Center with subspecialty expertise in thoracic and breast surgical pathology and a particular academic interest in the integration of artificial intelligence, computational pathology, and quantitative methods into diagnostic practice. Dr. Cui completed residency training in Anatomic and Clinical Pathology at the Icahn School of Medicine at Mount Sinai, where Dr. Cui served as Chief Resident, followed by consecutive fellowships in Oncologic Surgical Pathology and Thoracic Pathology at Memorial Sloan Kettering Cancer Center. Dr. Cui’s principal clinical and academic interests include neoplastic lung pathology, thymic lesions, mesothelioma, and interstitial lung disease, with an additional interest in breast pathology. A major focus of Dr. Cui’s academic work is artificial intelligence and computational pathology. Dr. Cui has studied machine-learning approaches for pathology image recognition and classification and has designed and fine-tuned multiple domain-specific AI models intended for practical applications in pathology. These projects span histopathologic image interpretation, differential diagnosis, thoracic pathology and radiology integration, medical knowledge retrieval, scientific writing, and transformation of unstructured medical information into structured data for downstream analysis. Dr. Cui has also explored strategies to improve the reliability of large language models in medicine, including approaches designed to reduce data hallucination, which are the subject of a pending U.S. patent. This work is complemented by invited lectures on GPT-driven AI, language-model fine-tuning, and their applications in pathology informatics and daily practice. Dr. Cui also has a longstanding interest in statistics, quantitative analysis, and data-driven biomedical research. Prior research has encompassed high-throughput proteomics, molecular profiling, signaling-pathway analysis, biomarker discovery, and computational pathology. This quantitative perspective increasingly informs Dr. Cui’s work in machine learning, where careful data curation, model validation, statistical interpretation, and clinically meaningful performance assessment are essential for translating computational tools into pathology practice. Through the convergence of subspecialty diagnostic pathology, artificial intelligence, and quantitative methodology, Dr. Cui’s academic goal is to develop practical and reliable computational tools that augment pathologists’ expertise, improve diagnostic precision, and advance personalized patient care. Education Medical Education Nantong University (2008), MD Medical Education Southern Medical University (2012), Ms Residency Icahn School of Medicine -- Mount Sinai Morningside and Mount Sinai West (2024), Anatomic & Clinical Pathology Fellowship Memorial Sloan Kettering Cancer Center (2025), Surgical Oncology Pathology Fellowship Memorial Sloan Kettering Cancer Center (2026), Thoracic Pathology Research Interest Artificial Intelligence Breast Pathology Fine-Tuning Large Language Models Interstitial Pneumonia Mesothelioma Neoplastic Lung Disease Thymic Lesions Publications Featured Publications Advances in the Clinical Application of High-throughput Proteomics. Cui M, Deng F, Disis ML, Cheng C, Zhang L, Explor Res Hypothesis Med 2024 9 3 209-220 The imbalance of circulating monocyte subgroups with a higher proportion of the CD14+CD16+CD163+ phenotype in patients with preeclampsia. Gong F, Wang J, Lu N, Wang J, Wang J, Shi X, Cui M, Cui L, Immunol Lett 2023 Jan 253 1-7 Omicron-adapted vaccines might require longer follow-up to reveal true benefits. Tang L, Zhang R, Cui M, Hong P, Lancet Microbe 2022 Oct High-throughput proteomics: a methodological mini-review. Cui M, Cheng C, Zhang L, Lab Invest 2022 Aug Finite neutralisation breadth of omicron after repeated vaccination. Zhu Y, Lu Y, Tang L, Zhou C, Liang R, Cui M, Xu Y, Zheng Z, Cheng Z, Hong P, Lancet Microbe 2022 Jul Association of neutralizing breadth against SARS-CoV-2 with inoculation orders of heterologous prime-boost vaccines. Zhu Y, Lu Y, Zhou C, Tong G, Gao M, Zhan Y, Wang Y, Liang R, Li Y, Gao T, Wang L, Zhang M, Cheng J, Gong J, Wang J, Zhang W, Qi J, Cui M, Zhu L, Xiao F, Zhu L, Xu Y, Zheng Z, Zhou Z, Cheng Z, Hong P, Med (N Y) 2022 Jun Post-recovery enhancement of anti-variant neutralisation after severe COVID-19. Lu Y, Zhu Y, Cui M, Cheng Z, Hong P, Lancet Microbe 2022 Feb SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection. Zhan Y, Zhu Y, Wang S, Jia S, Gao Y, Lu Y, Zhou C, Liang R, Sun D, Wang X, Hou Z, Hu Q, Du P, Yu H, Liu C, Cui M, Tong G, Zheng Z, Xu Y, Zhu L, Cheng J, Wu F, Zheng Y, Liu P, Hong P, Signal Transduct Target Ther 2021 10 6 1 368 Artificial intelligence and computational pathology. Cui M, Zhang DY, Lab Invest 2021 Apr 101 4 412-422 Clinical evidence of an interferon-glucocorticoid therapeutic synergy in COVID-19. Lu Y, Liu F, Tong G, Qiu F, Song P, Wang X, Zou X, Wan D, Cui M, Xu Y, Zheng Z, Hong P, Signal Transduct Target Ther 2021 Mar 6 1 107 Results 1-10 of 39 1 2 3 4 Next Last Books Featured Books Chapter 8: Diagnostic Methodology and Technology. In Molecular Genetic Pathology, 2nd edition Wu J, Ye F, Cui M, Shibata R, Xu R, Chen L, Zhang DY (2013). Springer-Verlag New York Chapter 14: Instrumentation for Molecular Testing. In Molecular Genetic Pathology, 2nd edition Laser J, Cui M, Petersen BE, Ye F, Zhang DY (2013). Springer-Verlag New York Chapter 25: Molecular Virology. In Molecular Genetic Pathology, 2nd edition Ye F, Cui M, khasawneh R, Shibata R, Wu J, Sharaan M, Zhang DY (2013). Springer-Verlag New York Chapter 26: Molecular Bacteriology and Mycobacteriology. In Molecular Genetic Pathology, 2nd edition Shin JH, Sharaan M, Wu J, Cui M, Zhang DY, Tang YW (2013). Springer-Verlag New York Chapter 29: Molecular Microbiology Epidemiology. In Molecular Genetic Pathology, 2nd edition Cui M, Ye F, Zhang DY (2013). Springer-Verlag New York Chapter 17: Probe Amplification Technologies. In Advanced Techniques in Diagnostic Microbiology, 2nd edition Ye F, Cui M, Feng T, Lee I, Wu J, Yin BJ, Zhang DY (2013). Springer US Chapter III: office-based pathology laboratory. In An Outline of Office-based Bladder and Prostate Biopsy Pathology Zhang DY, Cui M, Wu J (2019). Nova Science Publishers Honors & Awards Lizhen Gui AwardChinese American Pathologists Association (CAPA) (2023) Resident and Fellow of the MonthIcahn School of Medicine at Mount Sinai (ISMMS) Graduate Medical Education (GME) (2022) COVID-19 Contribution AwardChinese American Pathologists Association (CAPA) (2021) STAR Employee Recognition Award of Mount Sinai Health System (2021) Professional Associations/Affiliations American Society of Clinical Pathology (ASCP) Association for Pathology Informatics (API) Chinese American Pathologists Association (CAPA) College of American Pathologists (CAP) Digital Pathology Association (DPA) International Association for the Study of Lung Cancer (IASLC) International Thymic Malignancy Interest Group (ITMIG) Pulmonary Pathology Society (PPS) United States and Canadian Academy of Pathology (USCAP)
